Literature DB >> 13294011

The treatment of human pulmonary tuberculosis with cycloserine: progress report.

I G EPSTEIN, K G NAIR, L J BOYD.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1956        PMID： 13294011     DOI： 10.1378/chest.29.3.241

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  2 in total

1.  d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.

Authors:  Devyani Deshpande; Jan-Willem C Alffenaar; Claudio U Köser; Keertan Dheda; Moti L Chapagain; Noviana Simbar; Thomas Schön; Marieke G G Sturkenboom; Helen McIlleron; Pooi S Lee; Thearith Koeuth; Stellah G Mpagama; Sayera Banu; Suporn Foongladda; Oleg Ogarkov; Suporn Pholwat; Eric R Houpt; Scott K Heysell; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

2.  Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes.

Authors:  Dimitrios Evangelopoulos; Gareth A Prosser; Angela Rodgers; Belinda M Dagg; Bhagwati Khatri; Mei Mei Ho; Maximiliano G Gutierrez; Teresa Cortes; Luiz Pedro S de Carvalho
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.